Literature DB >> 16733353

Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease.

D A Lozsadi1, A J Larner.   

Abstract

BACKGROUND/AIMS: To investigate the frequency of epilepsy at the time of diagnosis of Alzheimer's disease (AD).
METHODS: Observational study, Cognitive Function Clinic population, over a 6-year period (2000-2005 inclusive).
RESULTS: In a cohort of 177 patients with newly diagnosed clinically probable AD, 12 (6.8%) had a history of seizure disorder and/or were using anti-epileptic medications at the time of diagnosis. In 6 of these cases (3.4%), seizure onset was approximately concurrent with the onset of cognitive decline, and no symptomatic or provoking factor for seizures other than AD was identified.
CONCLUSION: Although epileptic seizures are more common later in the course of AD, nonetheless they may accompany the onset of, and be symptomatic of, the disease, perhaps reflecting a shared pathogenesis. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733353     DOI: 10.1159/000093664

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  35 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

2.  Distinctive roles of different beta-amyloid 42 aggregates in modulation of synaptic functions.

Authors:  Hsueh-Cheng Chiang; Koichi Iijima; Inessa Hakker; Yi Zhong
Journal:  FASEB J       Date:  2009-03-02       Impact factor: 5.191

Review 3.  RIP at the Synapse and the Role of Intracellular Domains in Neurons.

Authors:  Yan Jun Lee; Toh Hean Ch'ng
Journal:  Neuromolecular Med       Date:  2019-07-25       Impact factor: 3.843

4.  Corticothalamic network dysfunction and Alzheimer's disease.

Authors:  Rohan Jagirdar; Jeannie Chin
Journal:  Brain Res       Date:  2017-09-15       Impact factor: 3.252

5.  Synaptic Adhesion Molecule Pcdh-γC5 Mediates Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Yanfang Li; Zhicai Chen; Yue Gao; Gaojie Pan; Honghua Zheng; Yunwu Zhang; Huaxi Xu; Guojun Bu; Hui Zheng
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

6.  Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.

Authors:  Alexander J Beagle; Sonja M Darwish; Kamalini G Ranasinghe; Alice L La; Elissaios Karageorgiou; Keith A Vossel
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  ΔFosB Regulates Gene Expression and Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease.

Authors:  Brian F Corbett; Jason C You; Xiaohong Zhang; Mark S Pyfer; Umberto Tosi; Daniel M Iascone; Iraklis Petrof; Anupam Hazra; Chia-Hsuan Fu; Gabriel S Stephens; Annie A Ashok; Suzan Aschmies; Lijuan Zhao; Eric J Nestler; Jeannie Chin
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

Review 8.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

Review 9.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

10.  Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.

Authors:  D M Wilcock; M P Vitek; C A Colton
Journal:  Neuroscience       Date:  2009-01-19       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.